Suppr超能文献

来自不同幽门螺杆菌抗原的抗原性和保守肽。

Antigenic and conserved peptides from diverse Helicobacter pylori antigens.

机构信息

CIMOSM - Centro de Investigação em Modelação e Otimização de Sistemas Multifuncionais, ISEL - Instituto Superior de Engenharia de Lisboa, Instituto Politécnico de Lisboa, R. Conselheiro Emídio Navarro 1, 1959-007, Lisboa, Portugal.

出版信息

Biotechnol Lett. 2022 Mar;44(3):535-545. doi: 10.1007/s10529-022-03238-x. Epub 2022 Mar 11.

Abstract

Since the revolutionary finding of Helicobacter pylori as a common bacterial infection, that a high research effort for its eradication has been conducted. Epitope based-vaccine presents advantages over protein-based, as they can be designed to contain epitopes from diverse proteins, therefore, more easily representing the immune-variability of the bacterial population, while minimizing the toxicity associated to some whole proteins. In the present work, an iterative method, to design antigenic and conserved B-epitopes from diverse virulent factors of H. pylori, was established. The method considered the trade-off between epitopes antigenicity and conservation among the bacterial population. For the method validation, five virulent factors from H. pylori were selected. From each virulent factor, two epitopes were predicted, each with twelve residues of aminoacids. The corresponding ten peptides were synthesised and evaluated by enzyme-linked immunosorbent assay using polyclonal antibodies raised against a specific H. pylori strain. All ten peptides were recognised by the antibodies and were consequently antigenic and conserved. This result could strongly contribute to the design of a multivalent epitope-based vaccine, representing the immunogenetic variability within the bacterial population, leading to a sustained and effective immunogenic protection.

摘要

自发现幽门螺杆菌(Helicobacter pylori)是一种常见的细菌感染以来,人们进行了大量的研究来根除它。基于表位的疫苗比基于蛋白质的疫苗具有优势,因为它们可以设计成包含来自不同蛋白质的表位,因此更容易代表细菌群体的免疫变异性,同时最大限度地减少与一些完整蛋白质相关的毒性。在本工作中,建立了一种从幽门螺杆菌的多种毒力因子中设计抗原性和保守性 B 表位的迭代方法。该方法考虑了表位抗原性和细菌群体之间的保守性之间的权衡。为了验证该方法,选择了幽门螺杆菌的五种毒力因子。从每种毒力因子中预测了两个表位,每个表位包含十二个氨基酸残基。相应的十个肽被合成,并使用针对特定幽门螺杆菌菌株的多克隆抗体通过酶联免疫吸附试验进行评估。所有十个肽都被抗体识别,因此具有抗原性和保守性。这一结果可能会极大地促进多价基于表位的疫苗的设计,代表细菌群体内的免疫遗传变异性,从而实现持续有效的免疫保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd7/8916697/1a9ede603808/10529_2022_3238_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验